Citigroup’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
NCM
6CM
PFCS
VCM
CCM
GCGM
DMC
MC
WP
Citigroup's GUTS Position: Q1 2026 in Review
Citigroup sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 35,076 shares — an estimated $77.2K sold.
Citigroup first reported a position in GUTS in Q1 2024 and held it in 8 quarters. The position peaked at $353K in Q1 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.
- Citigroup reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
- Citigroup sold 35,076 Fractyl Health shares in Q1 2026, an estimated $77.2K.
- Citigroup first reported a position in Fractyl Health in Q1 2024 and held it in 8 quarters.
- Citigroup's Fractyl Health position peaked at $353K in Q1 2024.
- 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.